1. Home
  2. ANIP vs KW Comparison

ANIP vs KW Comparison

Compare ANIP & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • KW
  • Stock Information
  • Founded
  • ANIP 2001
  • KW 1977
  • Country
  • ANIP United States
  • KW United States
  • Employees
  • ANIP N/A
  • KW N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • KW Real Estate
  • Sector
  • ANIP Health Care
  • KW Finance
  • Exchange
  • ANIP Nasdaq
  • KW Nasdaq
  • Market Cap
  • ANIP 1.2B
  • KW 1.4B
  • IPO Year
  • ANIP N/A
  • KW 1992
  • Fundamental
  • Price
  • ANIP $57.94
  • KW $8.90
  • Analyst Decision
  • ANIP Buy
  • KW Hold
  • Analyst Count
  • ANIP 7
  • KW 1
  • Target Price
  • ANIP $77.33
  • KW $13.00
  • AVG Volume (30 Days)
  • ANIP 172.8K
  • KW 465.7K
  • Earning Date
  • ANIP 02-28-2025
  • KW 02-26-2025
  • Dividend Yield
  • ANIP N/A
  • KW 5.40%
  • EPS Growth
  • ANIP N/A
  • KW N/A
  • EPS
  • ANIP N/A
  • KW N/A
  • Revenue
  • ANIP $555,456,000.00
  • KW $483,200,000.00
  • Revenue This Year
  • ANIP $25.54
  • KW N/A
  • Revenue Next Year
  • ANIP $20.95
  • KW N/A
  • P/E Ratio
  • ANIP N/A
  • KW N/A
  • Revenue Growth
  • ANIP 23.60
  • KW N/A
  • 52 Week Low
  • ANIP $52.50
  • KW $7.85
  • 52 Week High
  • ANIP $70.81
  • KW $11.88
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 46.25
  • KW 43.26
  • Support Level
  • ANIP $58.37
  • KW $8.61
  • Resistance Level
  • ANIP $60.54
  • KW $8.96
  • Average True Range (ATR)
  • ANIP 1.69
  • KW 0.19
  • MACD
  • ANIP -0.21
  • KW 0.03
  • Stochastic Oscillator
  • ANIP 20.28
  • KW 41.91

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

Share on Social Networks: